Pathstone Family Office’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,000	Closed	-$24K	–	847
2020 Q2	$24K	Hold	1,000	–	–	﹤0.01%	403
2020 Q1	$18K	Buy	+1,000	New	+$18K	﹤0.01%	427